Community Liver Alliance NASH Update

November 10, 2020

Emerging therapies for NASH/NAFLD, both pharmacologic and endoscopic

Emerging nutritional and weight management research related to NASH/NAFLD

Extra-hepatic manifestations associated with NASH, management options and screening options

Target Audience

This program is directed to hepatologists, gastroenterologists, primary care physicians and other health care providers involved in the management of patients with liver disease.

Learning Objectives

At course completion, attendees should have an;

Increase knowledge base regarding therapy for NASH/NAFLD related to medication and endoscopic treatments;

Increase knowledge base regarding management for NASH/NAFLD related to nutritional and weight therapies;

Increased knowledge base regarding options of extra-hepatic manifestations of NASH

Additional Information

Course summary
Available credit: 
  • 3.00 AAPA Category I CME
  • 3.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 3.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 3.00 Attendance
Course opens: 
09/26/2020
Course expires: 
12/31/2020
Event starts: 
11/10/2020 - 8:00am
Event ends: 
11/10/2020 - 6:00pm

Schedule


6:00 PM

Welcome

Jill Harlan, PA-C

Program Manager

Community Liver Alliance

Suzanna Masartis

Executive Director

Community Liver Alliance


6:05 PM

How Did We Get Here... The Role of Nutrition in Fatty Liver Disease

Karen Jerome-Zapadka, MD

Medical Director

Valley Gastroenterology Associates Center for Obesity Medicine

Beaver, PA


6:20 PM

Your Patient Has a Fatty Liver...What now?

Karen Jerome-Zapadka, MD

Medical Director

Valley Gastroenterology Associates Center for Obesity Medicine

Beaver, PA


6:35 PM

Progression, Surveillance and Treatment NASH/ESLD

Cristina Strahotin, MD

Allegheny Health Network

Pittsburgh, PA


6:55 PM

Need for Bariatric Surgery in NASH Patients

Joseph Lim, MD

Professor of Medicine

Director, Viral Hepatitis Program

Yale School of Medicine


7:15 PM

COVID-19 and Liver Disease

Tuesdae Stainbrook, DO, MPH

Medical Director

TruCare Internal Medicine

Dubois, PA


7:35 PM

Pediatric NASH

Patrick McKiernan, MD

Director, Pediatric Hepatology Program

Children’s Hospital of Pittsburgh

Pittsburgh, PA


7:55 PM

Discussion: Barriers for treatment of NASH

Andrew DeMarco, MD, FACP

Medical Director

Connected Health

Wexford, PA


8:15 PM

Managing Psychological Stressors of Liver Disease

Jennifer Pate, MD

Baylor St. Lukes Medical Center Psychiatry

Houston, TX


8:35 PM

Panel Discussion

Jill Harlan, PA-C

Program Manager

Community Liver Alliance

Kelly Martin, RN, MSN, CRNP

Community Liver Alliance

Pittsburgh, PA


9:00 PM

Adjourn

 

Live Virtual Program
Pittsburgh
United States

Faculty Disclosure

 All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.
 

The following relevant financial relationships were disclosed:

Tuesdae Stainbrook, DO, MPH – CE Speakers Bureau, AbbVie, Gilead

Tuesdae Stainbrook, DO, MPH - Grant/Research Support, Gilead

Jennifer Pate, MD - CE Speakers Bureau, Intercept

Joseph Lim, MD - Grant/Research Support, Allergan, Conatus, Genfit, Gilead, Intercept
 

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Continuing Education Credit
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and Community Liver Alliance. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 3.0 contact hours.

Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 3.00 AAPA Category I CME
  • 3.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 3.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 3.00 Attendance
Please login or register to take this course.

If you have any questions please contact the conference manager, Suzanna Masartis.

Suzanna Masartis
Executive Director
412-400-9343